We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Weighs Rules Around Protection of Trade Secrets in Clinical Trials
The item has been added to your shopping cart.
EMA Weighs Rules Around Protection of Trade Secrets in Clinical Trials
January 21, 2015
The European Medicines Agency appears to be backing off promises to protect industry trade secrets in its new clinical trials database, and is developing scenarios under which it would release commercially confidential information.